-+ 0.00%
-+ 0.00%
-+ 0.00%

B. Riley Securities Upgrades Cognition Therapeutics to Buy, Raises Price Target to $1.5

Benzinga·12/19/2024 16:26:36
Listen to the news
B. Riley Securities analyst Mayank Mamtani upgrades Cognition Therapeutics (NASDAQ:CGTX) from Neutral to Buy and raises the price target from $1 to $1.5.